Fresh Ownership Interest Emerges as Core Scientific Attracts Big-Institution Buyers

Core Scientific US21874A1060

Core Scientific is drawing heightened attention from institutional investors after a series of disclosures filed with the SEC. The Susquehanna Group has disclosed a 5.6% stake in the company, totaling 17,376,097 shares, held through entities including G1 Execution Services and the Susquehanna Investment Group. Because this investment is categorized as passive, the group has indicated it does not seek to exert direct influence over management or strategic direction.

In parallel, Helix Partners Management has clarified the composition of its position, now standing at 5.6 million shares?valued at roughly $81.5 million. The fund added 350,000 shares in the fourth quarter, reinforcing its stance.

• New Major Holder: Susquehanna Group reports a 5.6% stake (17,376,097 shares) managed through linked affiliates, with passive status toward governance and strategy.
• Position Increase: Helix Partners Management now owns 5.6 million Core Scientific shares, worth about $81.5 million, following an additional 350,000 shares bought in Q4.
• Analyst Outlook: Keefe, Bruyette & Woods uplifts its price target to $25.00 per share.
• Key Revenue Anchor: A 12-year contract with CoreWeave underpins a substantial revenue runway, with a total value of approximately $8.7 billion.

The High-Performance Computing Pivot

Analysts view Core Scientific?s pivot from primarily Bitcoin mining toward hosting for High-Performance Computing (HPC) as a potential driver of more predictable revenue. Researchers at Keefe, Bruyette & Woods recently reiterated an Outperform rating, lifting their price target to $25.00.

A central pillar of this valuation is the enhanced revenue visibility enabled by a 12-year agreement with CoreWeave, a provider of AI infrastructure. The contract carries an approximate total value of $8.7 billion and is seen as a cornerstone for Core Scientific?s transition into the HPC market.

The stock traded at $18.09 per share at the close on Friday. Core Scientific is scheduled to report fourth-quarter 2025 results on February 25, 2026. Market participants will be looking for tangible proof of the HPC strategy in action and for confirmation of the company?s long-term financial targets.